UTS2R and cardiac hypertrophy: Although the use of some non-peptide U-II receptor antagonists has shown that blockade of the U-II/GPR14 system attenuated cardiac hypertrophy and improved cardiac function in animal models [12, 13, 14], such antagonists lack potency and have not achieved effects on mortality in heart failure animal models [14, 15].